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Oren J. Cohen, MD;* and Anthony S. Fauci, MD* 
One of the most complex issues regarding the patho- 
genesis of human immunodeficiency virus (HIV) infec- 
tion is that of sexual transmission. Sexual transmission of 
HIV is dependent on a number of variables that are oper- 
ative in both the transmitting individual and the unin- 
fected sexual partner. Although several recent studies 
have advanced the understanding of the factors that 
determine whether or not HIV is transmitted during a 
sexual encounter, more questions remain unanswered 
than answered.’ 
Sexual transmission of HIV may occur when a suffi- 
cient amount of infectious virus penetrates the mucosa 
of the uninfected partner. Factors that increase the 
amount and virulence of virus delivered, that weaken the 
integrity of the local tissue barriers in the uninfected 
partner, or that hamper the generation of an effective 
local and systemic immune response in the uninfected 
partner would be expected to increase the likelihood of 
transmission. In this regard, the frequency and type of 
sexual encounter between the HIV-infected and unin- 
fected partners are important determinants of transmis- 
sion. The frequency of unprotected intercourse has been 
shown in many studies to bear a direct relation to the risk 
of transmission,2 although the exact nature of the statis- 
tical relation is complex and apparently non-parametric3 
The inherent fragility of the anorectal mucosa creates a 
predisposition to traumatic abrasion that explains the 
high-risk nature of unprotected anal intercourse. The pres- 
ence of genital ulcerative disease also may enhance trans- 
mission of HIV by physical disruption of mucosal barriers 
and by recruitment and concentration of inflammatory 
cells that may serve as potential target cells at sites of 
high exposure. Other factors also may influence the local 
environment in which transmission may occur; these 
include, among others, male or female circumcision, 
endogenous and exogenous hormonal influences on the 
vaginal mucosa and cervical epithelium, and topical 
agents applied to the vagina or rectum that may induce 
mucosal irritation2 
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The study of individuals who have been exposed to 
HIV and who remain uninfected (“exposed-uninfected” 
[E-U]) has recently yielded important insights into host 
factors that may protect against HIV infection. To gain 
entry into target cells, HIV utilizes the CD4 molecule in 
addition to a second “coreceptor” molecule. Human 
immunodeficiency virus coreceptors are seven-trans- 
membrane G protein-coupled chemokine receptors. CC 
chemokine receptor (CCR)-5 serves as the major co- 
receptor for macrophage (M)-tropic strains of HIV, 
whereas CXC chemokine receptor (CXCR)4 is the major 
coreceptor for T-cell (Q-tropic strains of the virus.* Part 
of the observed bottleneck of transmission of M-tropic 
strains of HIV may be explained by the expression of 
CCR5 and absence of CXCR4 on Langerhans’ cells, which 
may be the first cells to be infected during sexual trans- 
mission of HIV5 Further studies are necessary to deter- 
mine whether a relation exists between the distribution 
and level of expression of HIV coreceptors in the vagi- 
nal and rectal mucosa and susceptibility to HIV infection. 
Approximately 1% of the Caucasian population is 
homozygous for a 32-base-pair deletion within the CCR5 
gene that encodes a protein devoid of HIV coreceptor 
activity; these individuals are highly resistant to HIV infec- 
tion 6-9 although other protective mechanisms clearly are 
operative in E-U individuals with normal CCR5 genes. 
Human immunodeficiency virus-specific cytotoxic T- 
lymphocyte (CTL) responses, T-helper responses, and 
secretory IgA responses in urine or vaginal secretions 
have been demonstrated in E-U individuals.‘0-12 In addi- 
tion, overproduction of P-chemokines, which inhibit repli- 
cation of M-tropic strains of HIV by binding to CCR5,13 
may play a role in protecting some E-U individuals against 
HIV infection.‘* The relative roles played by each of these 
factors in protecting against HIV infection in vivo remain 
to be determined. 
In this issue of the International Journal of Infec- 
tious Diseases, Denny et al add an interesting dimension 
to the study of sexual transmission of HIV1 Whereas most 
studies of couples who are discordant for HIV infection 
have focused on factors in the uninfected partner that 
may protect against HIV infection, Denny et al have 
focused instead on factors in the HIV-infected partner 
that may be associated with the efficiency of HIV trans- 
mission.’ The study examined the immunologic and viro- 
logic features among HIV-concordant couples and 
HIV-discordant couples. In comparing the transmitting 
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individuals within HIV-concordant relationslhips to the 
HIV-infected individuals within HIV-discordant relation- 
ships, it was found that viral load was significantly lower 
among the nontransmitters within the Hw-discordant 
relationship compared to the transmitters within the HIV- 
concordant relationships (median plasma viremia 25,000 
copies/ml vs. 93,000 copies/ml). In addition, the number 
of peripheral blood CDS+ T cells was significantly higher 
among nontransmitters compared with transmitters 
(median 1091 cells/yL vs. 693 cells/uL). Of note, the num- 
ber of peripheral blood CDS+ T cells was the most pow- 
erful discriminator of transmitters and nontransmitters 
in a multivariate analysis. With regard to markers of viral 
pathogenicity, the percentage of transmitters and non- 
transmitters harboring syncytium-inducing strains of HIV 
was nearly identical. Interpretation of the data is clouded 
somewhat by demographic differences between the trans- 
mitters and nontransmitters. In this regard, the seroposi- 
tive partners in HIV-concordant couples had been 
seropositive for 30 months, whereas those in HIV-dis- 
cordant couples had been seropositive for only 12 
months. Although the authors state that time since sero- 
conversion in the HIV-seropositive partner may be an 
unreliable indicator of exposure time of the seronegative 
partner, still one must consider that a longer exposure 
time may be a crucial determinant of transmission in this 
study. The frequency of vaginal intercourse and of con- 
dom use was similar in HIV-concordant and discordant 
couples; although the frequency of anal intercourse was 
higher among HIV-concordant compared with HIV-dis- 
cordant couples, this factor did not appear to be domi- 
nant.15 Interestingly, Hispanic or African-American 
ethnic&y was a strong independent predictor of HIV con- 
cordancy among couples. It is unlikely that the low fre- 
quency of the mutant CCR5 gene in non-Caucasian 
populations contributes significantly to this disparity 
between Caucasians and non-Caucasians since fewer than 
1% of the seronegative individuals among HIV-discordant 
couples would be expected to be protected against HIV 
infection by virtue of their CCR5 genotype.‘zs 
If a high CDS+ T-cell count in an HIV-infected indi- 
vidual is indeed associated with a reduced risk of HIV 
transmission, it would be of obvious interest to deter- 
mine what mechanisms might be responsible for such 
an association. High CDS+ T-cell counts are a common 
feature of HIV infection; persistent viral replication pre- 
sumably is responsible for the constant stimulation of 
CDS+ CTL responses throughout most of the course of 
HIV disease.r6 Human immunodeficiency virus-infected 
long-term nonprogressors often have high peripheral 
blood CDS+ T-cell counts,17Js possibly reflecting high fre- 
quencies of circulating HIV-specific CTL.18J9 Furthermore, 
waning HIV-specific CTL responses are associated with 
progression of HIV disease.“O These data, suggesting that 
HIV-specific CTLs curtail virus replication in vivo recently 
have been confirmed in a study demonstrating an inverse 
correlation between CTL frequency and plasma viral 
load.‘l It is, therefore, reasonable to assume that the non- 
transmitters in the study by Denny et al may harbor vig- 
orous HIV-specific CTL responses that contribute to 
lower viral load and reduced risk of viral transmission. 
CDS+ T cells also may inhibit HIV replication and spread 
by mechanisms other than CTL responses. Non-cytolytic 
CDS+ T-cell-mediated HIV suppressor activity was first 
described 12 years ago by Walker et al.** Since then, it has 
been shown that this activity is mediated by soluble fac- 
tors, and correlates with partial protection against dis- 
ease progression.23 The discovery of the P-chemokines 
RANTES, macrophage inflammatory protein (MIP)-la, and 
MIP-1P as CDS-derived HIV suppressor factors heralded 
the discovery of HIV coreceptors13; their selectivity for 
inhibiting only M-tropic strains of HIV was later demon- 
strated to derive from the fact that these factors are lig- 
ands for CCR5.3 A convincing relationship between 
P-chemokine production and protection against disease 
progression has been difficult to demonstrate, at least in 
part because most studies have measured levels of these 
factors in the peripheral circulation or in supernatants 
from cells stimulated in vitro.** A recent study does sug- 
gest that higher blood levels of MIP-1~ may decrease the 
risk of HIV disease progression,25 and another demon- 
strated overproduction of the @chemokines in E-U indi- 
viduals with hemophilia. I4 In addition, it certainly remains 
possible that production of P-chemokines in relevant 
microenvironments may be physiologically important. 
Other CDS-derived suppressor factor candidates include 
interleukin-16 and macrophage-derived chemokine 
(MDC)-1,26~27 although the relevance of these factors in 
vivo remains undetermined. Several recent studies sug- 
gest that the list of CDS+ T-cell-derived HIV-suppressor 
factors will grow, because the HIV-suppressive activity of 
supernatants from CDS+ T cells cannot be entirely 
accounted for by known factors.28-31 
If high peripheral blood CDS+ T-cell counts are a 
marker of efficient CTL and HIV-suppressor factor 
responses, then the lower viral load and reduced risk of 
viral transmission in this group are not surprising; how- 
ever, this relation contrasts sharply with the situation in 
vertical transmission, where a direct relation exists 
between maternal CDS+ T-cell percentage and the risk of 
transmission3* Interestingly, Denny et al found that the 
CDS+ T-cell count was an independent predictor of non- 
transmission and was in fact a more powerful predictor 
than plasma viral load. In this regard, it is interesting to 
speculate that the CDS+ T-cell count in these individuals 
may be a marker of efficient antiviral effector responses 
in the genital tract. Although plasma viral load seems to 
be a reasonable surrogate for levels of viral replication in 
lymphoid tissue and is a risk factor for transmission, it is 
not an ideal marker of viral load in genital tract secre- 
tions,‘,33 which presumably is most relevant with regard 
to the risk of transmission.34-36 Indeed Krieger et al found 
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an inverse relation between peripheral blood CDS+ T- 
cell counts and rates of HIV shedding in semen.37 With 
regard to the contrasting data in vertical transmission, it 
is possible that high CDS+ T-cell percentages may serve 
more as a marker for higher viral load than for effective 
antiviral immune responses during pregnancy, or that dif- 
ferences in the transmission environment (i.e., vertical 
vs. sexual) may account for the dichotomous behavior of 
the CDS-cell count in predicting transmission. 
Transmission of HIV is a complex, multifactorial 
process that is dependent on host factors in the HIV- 
infected individual, viral factors, the physical and cellular 
environment of exposure, and host factors in the unin- 
fected partner. The work of Denny et al sheds further 
light on the possible role of peripheral blood CDS+ T-cell 
counts as a marker of antiviral cellular immune responses 
in the genital tract. Such immune responses only recently 
have begun to be characterized,38 and further study no 
doubt will yield important insights into the pathogene- 
sis of HIV transmission. 
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